What does Tonix do?
TONIX is a biotechnology company that specializes in developing innovative therapies for various medical conditions. The company focuses on leveraging its proprietary technologies to create novel treatments primarily in the fields of immunology and infectious diseases. TONIX aims to improve patient outcomes through advanced research and development of its product pipeline.
- Sectors
- Real estate agencies Wholesalers
- Signals
-
Reporting lossesReporting losses € -80K
The company reported a loss in the latest financial year.
Poor liquidityPoor liquidity 0.78The current ratio is below 1: may be insufficient to cover short-term debt.
Strong equityStrong equity € 3.44MStrong equity provides a buffer against setbacks.
Low riskLow risk 32.1%Good solvency (> 30%) points to long-term financial stability.
Positive cashflowPositive cashflow € 220KPositive operating cash flow in the latest financial year.
Positive EBITDAPositive EBITDA € 254KPositive EBITDA: operating activities are profitable.
Financial ratios
|
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2025
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2024
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2023
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2022
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
|---|---|---|---|---|
|
€
519K
|
€
893K
|
€
1.24M
|
€
1.34M
|
|
|
€
254K
|
€
185K
|
€
1.11M
|
€
1.18M
|
|
|
€
-80K
|
€
-186K
|
€
771K
|
€
715K
|
|
|
€
3.44M
|
€
3.52M
|
€
3.70M
|
€
2.93M
|
|
|
32.05%
|
32.29%
|
55.58%
|
90.59%
|
|
|
€
6.88M
|
€
6.93M
|
€
2.52M
|
€
90K
|
|
|
€
9K
|
€
149K
|
€
37K
|
€
682K
|
Publications 53
All publications- Ontslagen - Benoemingen 10/07/2026
- Statuten (Vertaling, Cordinatie, Overige Wijzigingen, ) - Ontslagen - Benoemingen - Algemene Vergadering - Boekjaar 25/10/2023
- Maatschappelijke Zetel - Ontslagen - Benoemingen 06/02/2023
- Ontslagen - Benoemingen 17/09/2021
- Maatschappelijke Zetel 22/04/2021
Frequently asked questions
Answers to the most common questions about Tonix, based on official government data and the filed annual accounts.
What is the VAT number of Tonix?
The VAT number of Tonix is BE0420.691.968.
When was Tonix established?
Tonix was founded in 02-06-1980.
What is the official address of Tonix?
The official address of Tonix is Grote Markt 36 Izegem 8870.
What is the legal form of Tonix?
The juridical form of Tonix is Public limited company (NV/SA).
What is the annual revenue of Tonix?
The 2025 accounts of Tonix do not report revenue. Smaller companies that file abbreviated accounts are not required to publish it.
What does Tonix do?
TONIX is a biotechnology company that specializes in developing innovative therapies for various medical conditions. The company focuses on leveraging its proprietary technologies to create novel treatments primarily in the fields of immunology and infectious diseases. TONIX aims to improve patient outcomes through advanced research and development of its product pipeline.
Is Tonix a reliable company?
Tonix is a registered Rechtspersoon with company number 0420.691.968 and can be verified through the official CBE database.
Is Tonix still active?
Tonix currently has the status "Normal situation" and is active.